CPS1 and cancer: However, CRISPR-based therapies are now on the horizon for the treatment of debilitating diseases such as sickle cell disease [19], cancer [20], and, most recently, a rare condition called carbamoyl phosphate synthase 1 (CPS1) deficiency [21].